Real‐World Evidence of Crizanlizumab Showing Reductions in Vaso‐Occlusive Crises and Opioid Usage in Sickle Cell Disease.

Autor: DeBonnett, Laurie1 (AUTHOR) laurie.debonnett@novartis.com, Joshi, Vikas2 (AUTHOR), Silva‐Pinto, Ana Cristina3 (AUTHOR), Colombatti, Raffaella4 (AUTHOR), Pasanisi, Annamaria5 (AUTHOR), Arcioni, Francesco6 (AUTHOR), Cançado, Rodolfo D.7 (AUTHOR), Sarp, Séverine8 (AUTHOR), Sarkar, Rajendra2 (AUTHOR), Soliman, Wesam9 (AUTHOR)
Zdroj: European Journal of Haematology. Oct2024, p1. 10p. 3 Illustrations.
Databáze: Academic Search Ultimate
Externí odkaz: